EUVIMEDEUVIMED entdecken
Crossref

Impact of metformin on recurrence and progression in nonmuscle invasive bladder cancer

Muhammed Selçuk Özer, Volkan Şen, Sümeyye Terzi, Ozan Bozkurt, Ömer Demir, Güven Aslan, Mehmet Uğur Mungan, İlhan Çelebi, Ahmet Adil Esen

Developments and Experiments in Health and Medicine · 29.04.2026 · 40 (2) · 156-164

DOI: 10.18614/dehm.1687924 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Developments and Experiments in Health and Medicine, online erschienen am 29.04.2026. Verfasst von Muhammed Selçuk Özer und 8 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate the effect of metformin use on recurrence and progression in nonmuscle invasive bladder cancer patients (NMIBC). Material method: Patients who underwent primary transurethral bladder tumor resection between 2016 and 2020 were screened. Only patients with NMIBC were included in the study. The patients were divided into two groups according to the use of metformin and the groups were compared in terms of recurrence and progression.

Results

According to inclusion criteria 176 NIMBC patients were included in the study. Metformin use was detected in 37 patients. The demographic characteristics and follow-up times of the patients were similar between the user and nonuser groups. Recurrence was detected in only 8.1% of the metformin user group. On the other hand, the recurrence rate was 32.4% in the nonuser group. There was no progression in the metformin user group. But in the non-user group progression rate was 8,6%.

Conclusion

In our study, we found that recurrence and progression rates were lower in metformin-using patients. Prospective randomized trials are needed to understand the effects of metformin use on bladder cancer.

Zitieren

APA

Özer, M. S., Şen, V., Terzi, S., Bozkurt, O., Demir, Ö., Aslan, G., Mungan, M. U., Çelebi, İ., & Esen, A. A. (2026). Impact of metformin on recurrence and progression in nonmuscle invasive bladder cancer. Developments and Experiments in Health and Medicine, 40(2), 156-164. https://doi.org/10.18614/dehm.1687924

Vancouver

Özer MS, Şen V, Terzi S, Bozkurt O, Demir Ö, Aslan G, et al. Impact of metformin on recurrence and progression in nonmuscle invasive bladder cancer. Developments and Experiments in Health and Medicine. 2026;40(2):156-164. doi:10.18614/dehm.1687924

BibTeX
@article{zer2026,
  author = {Özer, Muhammed Selçuk and Şen, Volkan and Terzi, Sümeyye and Bozkurt, Ozan and Demir, Ömer and Aslan, Güven and Mungan, Mehmet Uğur and Çelebi, İlhan and Esen, Ahmet Adil},
  title = {Impact of metformin on recurrence and progression in nonmuscle invasive bladder cancer},
  journal = {Developments and Experiments in Health and Medicine},
  year = {2026},
  volume = {40},
  number = {2},
  pages = {156--164},
  doi = {10.18614/dehm.1687924}
}
Kostenlos starten →